Whether you are running an early Phase, a complete Phase 3 program or a bioequivalence clinical endpoint study, Symbio staff has specialized expertise, particularly with topical products.
The range of trial experience covers Dermatology, Inflammatory Disease, Aesthetics, Rare Disease, Medical Device and Gastroenterology.